324 related articles for article (PubMed ID: 31211964)
1. Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.
Andy UU; Amundsen CL; Honeycutt E; Markland AD; Dunivan G; Dyer KY; Korbly NB; Bradley M; Vasavada S; Mazloomdoost D; Thomas S;
Am J Obstet Gynecol; 2019 Nov; 221(5):513.e1-513.e15. PubMed ID: 31211964
[TBL] [Abstract][Full Text] [Related]
2. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
Amundsen CL; Richter HE; Menefee SA; Komesu YM; Arya LA; Gregory WT; Myers DL; Zyczynski HM; Vasavada S; Nolen TL; Wallace D; Meikle SF
JAMA; 2016 Oct; 316(13):1366-1374. PubMed ID: 27701661
[TBL] [Abstract][Full Text] [Related]
3. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.
Komesu YM; Amundsen CL; Richter HE; Erickson SW; Ackenbom MF; Andy UU; Sung VW; Albo M; Gregory WT; Paraiso MF; Wallace D;
Am J Obstet Gynecol; 2018 Jan; 218(1):111.e1-111.e9. PubMed ID: 29031894
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial.
Harvie HS; Amundsen CL; Neuwahl SJ; Honeycutt AA; Lukacz ES; Sung VW; Rogers RG; Ellington D; Ferrando CA; Chermansky CJ; Mazloomdoost D; Thomas S
J Urol; 2020 May; 203(5):969-977. PubMed ID: 31738113
[TBL] [Abstract][Full Text] [Related]
5. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
Amundsen CL; Komesu YM; Chermansky C; Gregory WT; Myers DL; Honeycutt EF; Vasavada SP; Nguyen JN; Wilson TS; Harvie HS; Wallace D;
Eur Urol; 2018 Jul; 74(1):66-73. PubMed ID: 29482936
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence.
Hendrickson WK; Zhang C; Jelovsek JE; Nygaard IE; Presson AP
J Urol; 2024 Jan; 211(1):134-143. PubMed ID: 37871326
[TBL] [Abstract][Full Text] [Related]
7. Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.
Richter HE; Amundsen CL; Erickson SW; Jelovsek JE; Komesu Y; Chermansky C; Harvie HS; Albo M; Myers D; Gregory WT; Wallace D;
J Urol; 2017 Oct; 198(4):890-896. PubMed ID: 28501541
[TBL] [Abstract][Full Text] [Related]
8. Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.
Richter HE; Moalli P; Amundsen CL; Malykhina AP; Wallace D; Rogers R; Myers D; Paraiso M; Albo M; Shi H; Nolen T; Meikle S; Word RA;
J Urol; 2017 Jun; 197(6):1487-1495. PubMed ID: 28089729
[TBL] [Abstract][Full Text] [Related]
9. Comparison of OnabotulinumtoxinA versus sacral neuromodulation for refractory urinary urge incontinence: A systematic review and meta-analysis of randomized controlled trials.
Niu HL; Ma YH; Zhang CJ
Int J Surg; 2018 Dec; 60():141-148. PubMed ID: 30415088
[TBL] [Abstract][Full Text] [Related]
10. Seminal papers in urology: two-year outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for refractory urgency urinary incontinence: a Randomized Trial.
Abd Wahab HHB; O'Callaghan M
BMC Urol; 2024 Jan; 24(1):16. PubMed ID: 38229041
[TBL] [Abstract][Full Text] [Related]
11. Sexual Activity After Bariatric Surgery: A Prospective Monocentric Study Using the PISQ-IR Questionnaire.
Treacy PJ; Mazoyer C; Falagario U; Iannelli A
J Sex Med; 2019 Dec; 16(12):1930-1937. PubMed ID: 31678099
[TBL] [Abstract][Full Text] [Related]
12. Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence.
Cameron AP; Smith AR; Lai HH; Bradley CS; Liu AB; Merion RM; Gillespie BW; Amundsen CL; Cella D; Griffith JW; Wiseman JB; Kreder KJ; Kenton KS; Helmuth ME; Fraser MO; Clemens JQ; Kirkali Z; Kusek JW; Siddiqui NY;
Neurourol Urodyn; 2018 Nov; 37(8):2586-2596. PubMed ID: 29635702
[TBL] [Abstract][Full Text] [Related]
13. Sexual function in women with anal incontinence using a new instrument: the PISQ-IR.
Pauls RN; Rogers RG; Parekh M; Pitkin J; Kammerer-Doak D; Sand P
Int Urogynecol J; 2015 May; 26(5):657-63. PubMed ID: 25392184
[TBL] [Abstract][Full Text] [Related]
14. Editorial Comment: Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.
Riccetto CLZ
Int Braz J Urol; 2020; 46(4):671-672. PubMed ID: 32374138
[No Abstract] [Full Text] [Related]
15. Minimal Clinically Important Difference (MCID) for the Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire - IUGA Revised (PISQ-IR).
Pruijssers B; van der Vaart L; Milani F; Roovers JP; Vollebregt A; van der Vaart H
J Sex Med; 2021 Jul; 18(7):1265-1270. PubMed ID: 34144912
[TBL] [Abstract][Full Text] [Related]
16. Sacral neuromodulation for combined faecal and urinary incontinence following obstetric anal sphincter injury.
Rydningen MB; Riise S; Wilsgaard T; Lindsetmo RO; Norderval S
Colorectal Dis; 2018 Jan; 20(1):59-67. PubMed ID: 28727899
[TBL] [Abstract][Full Text] [Related]
17. Does sacral nerve stimulation improve global pelvic function in women?
Jadav AM; Wadhawan H; Jones GL; Wheldon LW; Radley SC; Brown SR
Colorectal Dis; 2013 Jul; 15(7):848-57. PubMed ID: 23451900
[TBL] [Abstract][Full Text] [Related]
18. Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse.
Rahn DD; Richter HE; Sung VW; Hynan LS; Pruszynski JE
Am J Obstet Gynecol; 2023 Sep; 229(3):309.e1-309.e10. PubMed ID: 37244454
[TBL] [Abstract][Full Text] [Related]
19. Polish translation and validation of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR).
Grzybowska ME; Piaskowska-Cala J; Wydra DG
Int Urogynecol J; 2019 Jan; 30(1):55-64. PubMed ID: 29288345
[TBL] [Abstract][Full Text] [Related]
20. German translation and validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR).
Trutnovsky G; Nagele E; Ulrich D; Aigmüller T; Dörfler D; Geiss I; Reinstadler E; Angleitner-Flotzinger J; Ries JJ; Bjelic-Radisic V;
Int Urogynecol J; 2016 Aug; 27(8):1235-44. PubMed ID: 26883366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
